AUS
NZ
UK
CA
USA
IND
RooLife Group Ltd (ASX:RLG) has submitted a Final Director's Interest Notice confirming that Jeremy Baldock officially ceased his role as director on 1 July 2026. This notice, filed under ASX Listing Rule 3.19A.3 and section 205G of the Corporations Act, details Baldock's securities holdings at the time of his departure. Investors monitoring insider holdings and board changes at the e-commerce and cross-border retail company will note the disclosure includes 12.5 million fully paid ordinary shares held directly and 15 million unlisted options held indirectly through a superannuation vehicle.
Key Points
- Company: RooLife Group Ltd (ASX:RLG)
- Jeremy Baldock ceased as director on 1 July 2026
- Final interest notice reports 12,500,000 fully paid ordinary shares held directly by Baldock
- 15,000,000 unlisted options held indirectly via Sainter Nominees Pty Ltd as trustee for The Maximus super fund 2, divided into two tranches with exercise prices of $0.006 and $0.01, both expiring on 21 May 2027
- No interests in contracts were declared
- Investors should monitor for updates on board composition or leadership changes following Baldock's departure
Jeremy Baldock Officially Leaves RooLife Group Board as of 1 July 2026
RooLife Group Ltd has formally informed the market that Jeremy Baldock ended his tenure as director on 1 July 2026. The submission of an Appendix 3Z form — mandated by ASX Listing Rule 3.19A.3 — finalizes Baldock's disclosure obligations regarding his securities interests. The previous notice was dated 30 May 2025, indicating a gap of over a year between disclosures.
The Appendix 3Z is a compulsory disclosure under the ASX Listing Rules and the Corporations Act 2001, ensuring investors receive a comprehensive final record of a departing director’s relevant interests in company securities. This transparency is vital for smaller listed entities like RooLife Group, where insider holdings can significantly impact the register. The company did not provide reasons for Baldock’s departure in the update.
Baldock’s Direct Holding of 12.5 Million Fully Paid Ordinary Shares
Part 1 of the notice confirms Baldock held 12,500,000 fully paid ordinary shares in RooLife Group Ltd as the registered holder at the time he stepped down. This represents a significant stake for a director in a company of RooLife’s scale. These shares carry standard voting and dividend rights under the company’s constitution and the Corporations Act.
The disclosure clarifies the number of shares that Baldock may choose to trade or retain post-departure. Once no longer a director, Baldock is not subject to the continuous disclosure obligations related to his personal securities holdings. The company did not reveal whether Baldock plans to keep or dispose of these shares, which remains a personal decision.
Indirect Options Holdings via Sainter Nominees and The Maximus Super Fund 2
Part 2 reveals Baldock’s relevant interest in securities held indirectly. Sainter Nominees Pty Ltd, acting as trustee for The Maximus Super Fund 2, is the registered holder of these options. Baldock’s relevant interest arises from his controlling interest in that entity, as noted in the notice.
Holding securities through a superannuation fund trustee is common among Australian listed company directors and reflects standard wealth management and tax planning strategies. Despite not being the registered holder, Baldock’s control grants him a notifiable interest under the Corporations Act. The notice complies with regulatory requirements by capturing this indirect interest.
Two Tranches of Unlisted Options: Exercise Prices of $0.006 and $0.01, Expiring May 2027
The indirect interest comprises two tranches of unlisted options: 7,500,000 exercisable at $0.006 per option and 7,500,000 exercisable at $0.01 per option, both expiring on 21 May 2027. In total, Baldock held a relevant interest in 15,000,000 unlisted options at departure.
Unlisted options are not traded on the ASX and are subject to specific terms outlined in option deeds. The modest exercise prices align with typical options issued to directors of smaller capitalisation ASX-listed companies. Whether these options remain valid, lapse, or are exercised post-departure depends on the option agreements, which were not detailed in the filing.
No Contractual Interests Declared in Final Director Notice
Part 3 of the Appendix 3Z, which requires disclosure of any director interests in contracts, was marked "N/A" throughout. This indicates Baldock held no notifiable contractual interests with RooLife Group at the time of his resignation. This is typical for directors whose involvement is limited to governance rather than commercial or consulting roles.
The absence of contractual interests simplifies the regulatory context of Baldock’s departure, with no disclosed ongoing commercial arrangements requiring further monitoring. The final notice thus represents a clean break under the Corporations Act and ASX Listing Rules.
Regulatory Requirements for Departing ASX Directors Under Appendix 3Z
Introduced under ASX Listing Rule 3.19A.3 and section 205G of the Corporations Act 2001, the Appendix 3Z requires departing directors to provide a final comprehensive snapshot of their relevant securities interests as of their cessation date. This obligation is separate from the ongoing Appendix 3X and 3Y forms filed when directors join or update interests during tenure.
The purpose is to ensure the market has a complete record of insider holdings when a directorship ends, which is particularly important for market participants tracking substantial holders and insiders for investment decisions. RooLife Group’s filing fulfills its obligations in lodging on behalf of the former director.
Impact on RooLife Group Board Composition Following Baldock’s Exit
Baldock’s departure alters RooLife Group’s board makeup. The ASX-listed company focuses on cross-border e-commerce and digital retail, especially for Australian brands targeting international markets including China. Board changes at smaller companies can affect governance, strategy, and investor confidence. Market watchers will look for announcements on replacement appointments or committee restructuring.
The company’s update did not mention plans to appoint a successor or provide reasons for Baldock’s exit. Investors seeking further details on governance or strategy should consult future company releases or investor relations communications. The operational and strategic impact of this change will become clearer over time.
Time Gap Between Baldock’s Previous Disclosure and Final Notice
The Appendix 3Z states Baldock’s last notice was dated 30 May 2025, while his directorship ended on 1 July 2026. This 13-month interval suggests his disclosed securities holdings remained unchanged during that period, with no Appendix 3Y filings triggered.
This context is important for investors, indicating the final notice’s holdings — 12.5 million directly held shares and 15 million indirectly held options — reflect his position at departure, consistent with May 2025. Any future dealings by Baldock as a former director will not be subject to the same ASX disclosure rules.
Investor Considerations Regarding Baldock’s Share and Option Holdings
Investors tracking RooLife Group’s register should note that the 12.5 million ordinary shares could potentially enter the market in the future, subject to any escrow, voluntary restrictions, or personal decisions. No escrow or restrictions were disclosed.
The 15 million unlisted options, split between exercise prices of $0.006 and $0.01, expire on 21 May 2027 if not exercised beforehand. Whether Baldock retains rights to exercise these options post-departure depends on the option agreements, which were not detailed. Market participants should monitor for further disclosures ahead of the expiry. The immediate share price impact of this disclosure was not evident from public information.
